Your Location:
Home >
Browse articles >
Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study
RESEARCH | Updated:2026-06-10
    • Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study

    • Military Medical Research   Vol. 13, Issue 5, Pages: 689-705(2026)
    • DOI:10.1186/s40779-025-00659-3    

      CLC:
    • Received:10 January 2025

      Accepted:02 October 2025

      Online First:15 October 2025

      Published:2026-05

    Scan QR Code

  • Chao Zheng, Guo-Chao Zhang, Long Zhang, et al. Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study[J]. Military Medical Research, 2026, 13(5): 689-705. DOI: 10.1186/s40779-025-00659-3.

  •  
  •  

0

Views

6

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exosome autoantibody biomarkers for detection of lung cancer
China stroke surveillance report 2021
Establishment and effectiveness evaluation of a scoring system for exertional heat stroke by retrospective analysis
Relationship between expression of cathepsin D and proliferating cell nuclear antigen and prognosis in osteosarcoma
Cell-free DNA in sepsis: from molecular insights to clinical management

Related Author

Nurul Huda Rutt
Win Lwin Thuya
Janique Michelle Peyper
Tan Ti Myen
Nur Diana Anuar
Arif Anwar
Boon Cher Goh
Ling-Zhi Wang

Related Institution

Department of Haematology-Oncology, National University Cancer Institute, National 17 University Health System
Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 15 1E Kent Ridge Road
NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore
Cancer Science Institute of Singapore, National University of Singapore
0